Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 668

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 668
---
 the amended Merger Agreement, to be paid to
Kineta stockholders of record at the Effective Time will consist of an aggregate of up to a maximum of approximately 3,998,051 shares of TuHURA Common Stock, which is calculated by using the top-line share
value of $23,000,000 (consisting of the maximum value for the Initial Share Consideration of $16,500,000 plus the maximum value for Delayed Share Consideration of $6,500,000) and dividing by the TuHURA Share Value (3,998,051 shares x $5.7528 equals
$23,000,000).

After accounting for the expected Deficit Cash Consideration of $744,503 noted in the calculation above based on actual and
assumed cash payments to-date that are creditable against the cash component of the Merger Consideration, as well as the current estimated net working capital deficit (assumed to be the maximum allowed amount
of $6,000,000), the Initial Share Consideration expected is $15,755,497 (consisting of the maximum value of $16,500,000 less the Deficit Cash Consideration expected of $744,503) which translates to 2,738,751 shares of TuHURA Common Stock being
issued ($15,755,497 divided by the TuHURA Share Value of approximately $5.7528). Subject to further adjustment based on subsequent changes to the delayed net working capital or other amounts which could update the calculation of Merger Consideration
pursuant to the amended Merger Agreement, the Delayed Share Consideration is still expected to be the maximum value of $6,500,000

446

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

which translates to an additional 1,129,884 shares of TuHURA Common Stock being issued ($6,500,000 divided by the TuHURA Share Value of approximately $5.7528); for an aggregate share
consideration calculated of 3,868,635 shares of TuHURA Common Stock to be issued (as calculated through the issuance of 2,738,751 shares as the Initial Share Consideration plus the 1,129,884 shares as the Delayed Share Consideration) estimated on a
pro forma basis using the relevant details included in this unaudited pro forma condensed combined financial information.

As additional
estimated contingent consideration, Kineta stockholders